BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29956493)

  • 1. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study.
    Bompas E; Campion L; Italiano A; Le Cesne A; Chevreau C; Isambert N; Toulmonde M; Mir O; Ray-Coquard I; Piperno-Neumann S; Saada-Bouzid E; Rios M; Kurtz JE; Delcambre C; Dubray-Longeras P; Duffaud F; Karanian M; Le Loarer F; Soulié P; Penel N; Blay JY
    Cancer Med; 2018 Aug; 7(8):4023-4035. PubMed ID: 29956493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
    Ferrari A; Dileo P; Casanova M; Bertulli R; Meazza C; Gandola L; Navarria P; Collini P; Gronchi A; Olmi P; Fossati-Bellani F; Casali PG
    Cancer; 2003 Aug; 98(3):571-80. PubMed ID: 12879475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 4. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols.
    Gerber NK; Wexler LH; Singer S; Alektiar KM; Keohan ML; Shi W; Zhang Z; Wolden S
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):58-63. PubMed ID: 23414767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
    Liu YT; Wang CW; Hong RL; Kuo SH
    Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological characteristics, treatment outcome and prognostic factors in adult rhabdomyosarcoma: a monocentric retrospective study.
    Saadi M; Letaief F; Gabsi A; Mokrani A; Meddeb K; Mezlini A
    Pan Afr Med J; 2022; 41():246. PubMed ID: 35734321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study.
    Van Gaal JC; Van Der Graaf WT; Rikhof B; Van Hoesel QG; Teerenstra S; Suurmeijer AJ; Flucke UE; Loeffen JL; Sleijfer S; De Bont ES
    Anticancer Res; 2012 Oct; 32(10):4485-97. PubMed ID: 23060577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of presentation and outcome of ophthalmic rhabdomyosarcoma in Ibadan.
    Fasina O
    Afr J Med Med Sci; 2013 Jun; 42(2):165-9. PubMed ID: 24377202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature.
    Wang T; Gao X; Yang J; Guo W; Wu Z; Tang L; Cao S; Cai X; Liu T; Jia Q; Xiao J
    Clin Neurol Neurosurg; 2020 May; 192():105729. PubMed ID: 32058205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of pediatric middle ear tumors and analysis of the demographics, management, and survival of pediatric rhabdomyosarcomas of the middle ear.
    Janz TA; Camilon PR; Cheung AY; Nguyen SA; White DR; Weber PC
    Int J Pediatr Otorhinolaryngol; 2018 Sep; 112():109-112. PubMed ID: 30055718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyosarcoma in children: a SEER population based study.
    Perez EA; Kassira N; Cheung MC; Koniaris LG; Neville HL; Sola JE
    J Surg Res; 2011 Oct; 170(2):e243-51. PubMed ID: 21529833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
    Raney RB; Stoner JA; Walterhouse DO; Andrassy RJ; Donaldson SS; Laurie F; Meyer WH; Qualman SJ; Crist WM;
    Pediatr Blood Cancer; 2004 Jun; 42(7):618-25. PubMed ID: 15127417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre.
    Drabbe C; Benson C; Younger E; Zaidi S; Jones RL; Judson I; Chisholm J; Mandeville H; Fisher C; Thway K; Al Muderis O; Messiou C; Strauss D; Husson O; Miah A; Van der Graaf WTA
    Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):e27-e35. PubMed ID: 31350181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
    Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
    J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
    Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
    Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
    Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
    Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
    Turner JH; Richmon JD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case series of embryonal rhabdomyosarcoma of the head and neck in adults.
    Wagemans J; Beuselinck B; Nuyts S; Sciot R; Delaere P; Vander Poorten V; Dumez H; Hermans R; Schöffski P; Van den Bogaert W; Jorissen M; Clement PM
    Acta Clin Belg; 2010; 65(6):404-10. PubMed ID: 21268954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Characteristics, Prognostic Factors, and Treatment Outcomes for Adult Patients With Rhabdomyosarcoma (RMS).
    Rab SU; Bin Naeem S; Baloch NU; Jhatial MA; Waheed M; Fasih S; Kalsoom Awan UE
    Cureus; 2022 Dec; 14(12):e32961. PubMed ID: 36712747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
    Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.